Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q2 2024 · 10-Q
Revenue$90.34M$90.34M+17.0% vs Q2 2023 Net Income-$300.61M-$300.61MN/M vs Q2 2023 EPS Diluted-$1.94-$1.94N/M vs Q2 2023 Operating Income-$288,904,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$129,735,000N/M Margins · derivedOperating margin-319.8%−14.8 pt vs Q2 2023
Net margin-332.8%−15.8 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end